Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA to weigh easing limits on unproven peptides When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions What is the efficacy of intranasal BPC 157 (Body Protection Compound 157)? Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences